These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 35261519)
1. Utility of Urinary Biomarkers Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 as a Marker for Diagnosing the Presence of Renal Scar in Children with Vesicoureteral Reflux (VUR): A Cross-Sectional Study. Naik PB; Jindal B; Kumaravel S; Halanaik D; Rajappa M; Naredi BK; Govindarajan KK J Indian Assoc Pediatr Surg; 2022; 27(1):83-90. PubMed ID: 35261519 [TBL] [Abstract][Full Text] [Related]
2. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis. Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437 [TBL] [Abstract][Full Text] [Related]
3. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP. Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091 [TBL] [Abstract][Full Text] [Related]
4. The Utility of Noninvasive Urinary Biomarkers for the Evaluation of Vesicoureteral Reflux in Children. Colceriu MC; Aldea PL; Boț Răchişan AL; Bulată B; Delean D; Grama A; Mititelu A; Decea RM; Sevastre-Berghian A; Clichici S; Pop TL; Mocan T Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139407 [TBL] [Abstract][Full Text] [Related]
5. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury. Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient. Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570 [TBL] [Abstract][Full Text] [Related]
7. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin. Yilmaz A; Sevketoglu E; Gedikbasi A; Karyagar S; Kiyak A; Mulazimoglu M; Aydogan G; Ozpacaci T; Hatipoglu S Pediatr Nephrol; 2009 Dec; 24(12):2387-92. PubMed ID: 19649660 [TBL] [Abstract][Full Text] [Related]
8. KIM-1 and NGAL: new markers of obstructive nephropathy. Wasilewska A; Taranta-Janusz K; Dębek W; Zoch-Zwierz W; Kuroczycka-Saniutycz E Pediatr Nephrol; 2011 Apr; 26(4):579-86. PubMed ID: 21279810 [TBL] [Abstract][Full Text] [Related]
9. Urine interleukin-8 as a marker of vesicoureteral reflux in infants. Galanakis E; Bitsori M; Dimitriou H; Giannakopoulou C; Karkavitsas NS; Kalmanti M Pediatrics; 2006 May; 117(5):e863-7. PubMed ID: 16585276 [TBL] [Abstract][Full Text] [Related]
10. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study. Pang HM; Qin XL; Liu TT; Wei WX; Cheng DH; Lu H; Guo Q; Jing L Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4203-4213. PubMed ID: 29028077 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of Urinary Neutrophil Gelatinase-associated Lipocalin as a Biomarker in Pediatric Vesicoureteral Reflux Assessment. Amiri R; Faradmal J; Rezaie B; Sedighi I; Sanaei Z; Solgi G Iran J Kidney Dis; 2020 Sep; 14(5):373-379. PubMed ID: 32943592 [TBL] [Abstract][Full Text] [Related]
12. The Role of Urinary NGAL in the Management of Primary Vesicoureteral Reflux in Children. Gavrilovici C; Dusa CP; Iliescu Halitchi C; Lupu VV; Spoiala EL; Bogos RA; Mocanu A; Gafencu M; Lupu A; Stoica C; Starcea IM Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175609 [TBL] [Abstract][Full Text] [Related]
13. Urinary neutrophil gelatinase-associated lipocalin (uNGAL) and kidney injury molecule-1 (uKIM-1) as markers of active lupus nephritis. Ibrahim WHM; Sabry AA; Abdelmoneim AR; Marzouk HFA; AbdelFattah RM Clin Rheumatol; 2024 Jan; 43(1):167-174. PubMed ID: 37516706 [TBL] [Abstract][Full Text] [Related]